Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma

Figure 1 Flow diagram of the enrolled patients. BCLC: Barcelona Clinic Liver Cancer; HCC: Hepatocellular carcinoma; PA-TACE: Postoperative adjuvant transcatheter arterial chemoembolization.

Figure 2 Kaplan-Meier curve for liver cancer survival. A: Original data; B: Matched data. PA-TACE: Postoperative adjuvant transcatheter arterial chemoembolization.

Figure 3 Kaplan-Meier curve for liver cancer survival in the low and high ferritin-to-hemoglobin ratio group. A: Low ferritin-to-hemoglobin ratio; B: High ferritin-to-hemoglobin ratio. PA-TACE: Postoperative adjuvant transcatheter arterial chemoembolization.

Figure 4 Kaplan-Meier curve for liver cancer survival in patients with and without microscopic vascular invasion. A: Absence of microscopic vascular invasion; B: Presence of microscopic vascular invasion. PA-TACE: Postoperative adjuvant transcatheter arterial chemoembolization.